We are live on ! Find out more
BIA

Biondo Investment Advisors Portfolio holdings

AUM $780M
1-Year Est. Return 21.03%
This Fund
S&P 500
This Quarter Est. Return
+4.27%
1 Year Est. Return
+21.03%
3 Year Est. Return
+89.14%
5 Year Est. Return
+116.93%
10 Year Est. Return
+716.27%
AUM
$502M
AUM Growth
-$19.7M
Cap. Flow
-$28.5M
Cap. Flow %
-5.67%
Top 10 Hldgs %
46.7%
Holding
85
New
Increased
52
Reduced
19
Closed
4

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$8.2M
2
CRM icon
Salesforce
CRM
+$6.89M
3
BABA icon
Alibaba
BABA
+$6.08M
4
AAPL icon
Apple
AAPL
+$5.65M
5
XYZ
Block Inc
XYZ
+$4.44M

Sector Composition

Rank Sector Weight
1 Healthcare 34.2%
2 Technology 19.72%
3 Financials 11.77%
4 Consumer Discretionary 10.05%
5 Communication Services 5.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMZN icon
26
Amazon
AMZN
$2.96T
$6.68M 1.33%
43,160
-340
-0.8% -$53.9K
BA icon
27
Boeing
BA
$185B
$6.47M 1.29%
25,387
+6,241
+33% +$1.39M
CHD icon
28
Church & Dwight Co
CHD
$24.5B
$6.31M 1.26%
72,007
+2,362
+3% +$197K
SO icon
29
Southern Company
SO
$107B
$6.11M 1.22%
97,373
+3,552
+4% +$213K
VZ icon
30
Verizon
VZ
$196B
$6.01M 1.2%
103,386
+4,814
+5% +$272K
MMM icon
31
3M
MMM
$94.3B
$5.95M 1.18%
36,642
+1,459
+4% +$218K
ITW icon
32
Illinois Tool Works
ITW
$85.3B
$5.89M 1.17%
26,590
+1,480
+6% +$307K
VFC icon
33
VF Corp
VFC
$5.89B
$5.85M 1.16%
73,190
+2,290
+3% +$186K
BMY icon
34
Bristol-Myers Squibb
BMY
$132B
$5.78M 1.15%
91,506
+2,772
+3% +$172K
AMGN icon
35
Amgen
AMGN
$222B
$5.75M 1.14%
22,937
+656
+3% +$157K
LMT icon
36
Lockheed Martin
LMT
$136B
$5.71M 1.14%
15,355
+577
+4% +$198K
CVX icon
37
Chevron
CVX
$366B
$5.64M 1.12%
53,176
+3,407
+7% +$333K
DUK icon
38
Duke Energy
DUK
$97.3B
$5.47M 1.09%
56,186
+3,018
+6% +$275K
IOVA icon
39
Iovance Biotherapeutics
IOVA
$2.83B
$5.47M 1.09%
172,759
-624
-0.4% -$25.9K
SBUX icon
40
Starbucks
SBUX
$120B
$5.32M 1.06%
48,487
+2,472
+5% +$260K
GIS icon
41
General Mills
GIS
$19.7B
$5.13M 1.02%
83,746
+4,156
+5% +$240K
ADP icon
42
Automatic Data Processing
ADP
$108B
$5.01M 1%
26,584
+1,489
+6% +$258K
SPG icon
43
Simon Property Group
SPG
$72.3B
$4.93M 0.98%
43,350
+2,696
+7% +$281K
ZTS icon
44
Zoetis
ZTS
$30.5B
$2.36M 0.47%
14,955
+1,030
+7% +$163K
NOW icon
45
ServiceNow
NOW
$129B
$1.28M 0.26%
12,825
-170
-1% -$17.9K
DWAS icon
46
Invesco Dorsey Wright SmallCap Momentum ETF
DWAS
$450M
$1.28M 0.25%
15,030
+47
+0.3% +$4.04K
IWF icon
47
iShares Russell 1000 Growth ETF
IWF
$128B
$1.26M 0.25%
20,732
+280
+1% +$17K
IWP icon
48
iShares Russell Mid-Cap Growth ETF
IWP
$20.7B
$1.21M 0.24%
11,840
+195
+2% +$20.4K
MTUM icon
49
iShares MSCI USA Momentum Factor ETF
MTUM
$26.2B
$1.16M 0.23%
7,192
+148
+2% +$24.5K
FQAL icon
50
Fidelity Quality Factor ETF
FQAL
$1.46B
$1M 0.2%
22,094
+720
+3% +$31.8K

Similar funds

Biondo Investment Advisors's Q1 2021 Portfolio in Review

As of Q1 2021, Biondo Investment Advisors held 85 positions worth $502M, down 3.8% from $522M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Biondo Investment Advisors withdrew a net $28.5M in Q1 2021, closing 4 positions and reducing 19 holdings. Its most notable exit was Salesforce, an estimated $6.89M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, down from 37% a quarter earlier, followed by Technology and Financials.

Against the trend, Biondo Investment Advisors added an estimated $4.24M to Bed Bath & Beyond Inc.

  • Biondo Investment Advisors added most to Bed Bath & Beyond Inc in Q1 2021, an estimated $4.24M increase.
  • Biondo Investment Advisors's biggest Q1 2021 reduction was Vertex Pharmaceuticals, cutting an estimated $8.2M.
  • Biondo Investment Advisors fully exited Salesforce in Q1 2021, selling an estimated $6.89M.
  • Biondo Investment Advisors's ten largest holdings make up 47% of its $502M portfolio in Q1 2021.
  • Biondo Investment Advisors opened 0 new positions and closed 4 in Q1 2021.
  • Biondo Investment Advisors's portfolio value fell 3.8% quarter-over-quarter to $502M.

Based on Biondo Investment Advisors's 13F filing for Q1 2021, filed 11 May 2021.